Literature DB >> 21802829

Associations of benign prostatic hyperplasia with prostate cancer: the debate continues.

Ryan P Kopp, Stephen J Freedland, J Kellogg Parsons.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21802829     DOI： 10.1016/j.eururo.2011.07.005

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  3 in total

1.  The effect of benign lower urinary tract symptoms on subsequent prostate cancer testing and diagnosis.

Authors:  Christopher J Weight; Simon P Kim; Debra J Jacobson; Michaela E McGree; Stephen A Boorjian; R Houston Thompson; Bradley C Leibovich; R Jeffrey Karnes; Jennifer St Sauver
Journal:  Eur Urol       Date:  2013-01-04       Impact factor: 20.096

2.  Interactions between benign prostatic hyperplasia (BPH) and prostate cancer in large prostates: a retrospective data review.

Authors:  Shadi Al-Khalil; David Boothe; Trey Durdin; Sowmya Sunkara; Phillip Watkins; Shengping Yang; Allan Haynes; Werner de Riese
Journal:  Int Urol Nephrol       Date:  2015-11-21       Impact factor: 2.370

3.  Cost-effectiveness of a fixed-dose combination of solifenacin and oral controlled adsorption system formulation of tamsulosin in men with lower urinary tract symptoms associated with benign prostatic hyperplasia.

Authors:  Jameel Nazir; Lars Heemstra; Anke van Engen; Zalmai Hakimi; Cristina Ivanescu
Journal:  BMC Urol       Date:  2015-05-09       Impact factor: 2.264
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.